Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience
Author:
Funder
Fondazione Cariplo
Fondazione Umberto Veronesi
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference11 articles.
1. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak;Rothan;J Autoimmun,2020
2. Lebwohl M, Rivera-Oyola R, Murrell DF. Should biologics for psoriasis be interrupted in the era of COVID-19? [published online ahead of print March 18, 2020]. J Am Acad Dermatol. https://doi.org/10.1016/j.jaad.2020.03.031.
3. Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury;Liu;Natl Sci Rev,2020
4. Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence;Russell;Ecancermedicalscience,2020
5. Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed;Feldmann;Lancet,2020
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Etiopathogenesis of Psoriasis: Integration of Proposed Theories;Immunological Investigations;2024-01-19
2. Disparities in COVID-19 Mortality Amongst the Immunosuppressed: A Systematic Review and Meta-analysis for Enhanced Disease Surveillance;Journal of Infection;2024-01
3. The Characteristics of COVID-19 Symptoms and Skin Manifestations among Nonhospitalized COVID-19 Patients with Psoriasis during the Omicron Pandemic in China: A Single-Center Survey-Based Study;Dermatologic Therapy;2023-12-26
4. Microneedles Loaded with Dexamethasone and Epigallocatechin‐3‐gallate Reverse the Imbalance of Subcutaneous Immune Homeostasis for the Treatment of Psoriasis;Advanced Therapeutics;2023-12-03
5. A systematic review and meta‐analysis of investigating the mutual impact of COVID‐19 and psoriasis: Focusing on COVID‐19 course in psoriasis and the opinion on biologics in this setting;Immunity, Inflammation and Disease;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3